Adam Z Khan, Liam T Kane, Alayna Vaughan, Mark D Lazarus, Gerald R Williams, Surena Namdari
{"title":"Clinical and radiographic outcomes of revision to reverse shoulder arthroplasty with an augmented baseplate in the setting of glenoid bone loss.","authors":"Adam Z Khan, Liam T Kane, Alayna Vaughan, Mark D Lazarus, Gerald R Williams, Surena Namdari","doi":"10.1177/17585732261449624","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In revision to reverse shoulder arthroplasty (RSA), improper correction of glenoid deformity can result in over-medialization, baseplate fixation compromise, or variation in baseplate inclination or version. This study assessed clinical and radiographic outcomes of a non-custom augmented baseplate in the setting of revision to RSA.</p><p><strong>Methods: </strong>This was a retrospective cohort study of patients who underwent revision to RSA (from a prior shoulder arthroplasty procedure) with an augmented baseplate with a minimum 2-year follow-up. Radiographic and clinical outcomes were assessed.</p><p><strong>Results: </strong>Revision to RSA with a baseplate augment was performed in 25 patients (age 68.2 ± 8.9 years). There was improvement in elevation (98 to 146, p < 0.001), external rotation (28 to 39, p = 0.032), American Shoulder and Elbow Surgeon score (36.5 to 75.4, p < 0.001), Single Alpha Numeric Evaluation score (30.1 to 70.0, p < 0.001), and Visual Analog Pain Score (6.2 to 2.3, p < 0.001). One patient had radiographic evidence of baseplate mechanical failure (4%), two cases had postoperative instability (8%), and two cases had periprosthetic humerus fractures (8%).</p><p><strong>Discussion: </strong>In the setting of glenoid bone loss and revision to RSA, baseplate full and half-wedge \"off-the-shelf\" augments provide favorable short-term outcomes with a low rate of baseplate failure (4%) at a mean 2.7-year follow-up.</p><p><strong>Level of evidence: </strong>Level IV, retrospective cohort study.</p>","PeriodicalId":36705,"journal":{"name":"Shoulder and Elbow","volume":" ","pages":"17585732261449624"},"PeriodicalIF":1.2000,"publicationDate":"2026-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13179934/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shoulder and Elbow","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17585732261449624","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In revision to reverse shoulder arthroplasty (RSA), improper correction of glenoid deformity can result in over-medialization, baseplate fixation compromise, or variation in baseplate inclination or version. This study assessed clinical and radiographic outcomes of a non-custom augmented baseplate in the setting of revision to RSA.
Methods: This was a retrospective cohort study of patients who underwent revision to RSA (from a prior shoulder arthroplasty procedure) with an augmented baseplate with a minimum 2-year follow-up. Radiographic and clinical outcomes were assessed.
Results: Revision to RSA with a baseplate augment was performed in 25 patients (age 68.2 ± 8.9 years). There was improvement in elevation (98 to 146, p < 0.001), external rotation (28 to 39, p = 0.032), American Shoulder and Elbow Surgeon score (36.5 to 75.4, p < 0.001), Single Alpha Numeric Evaluation score (30.1 to 70.0, p < 0.001), and Visual Analog Pain Score (6.2 to 2.3, p < 0.001). One patient had radiographic evidence of baseplate mechanical failure (4%), two cases had postoperative instability (8%), and two cases had periprosthetic humerus fractures (8%).
Discussion: In the setting of glenoid bone loss and revision to RSA, baseplate full and half-wedge "off-the-shelf" augments provide favorable short-term outcomes with a low rate of baseplate failure (4%) at a mean 2.7-year follow-up.
Level of evidence: Level IV, retrospective cohort study.